261 replies to this topic

[Investment novice]

I agree certainly on the external influence. Interestingly the slow poison downtrend was very low volume trades and could even be from nercous individual investors who are taking prifits from previous buys at 29c to 40c. Going to gold.
The big institutional guys are still there. And its unlikely there will be a cheap acquisition or takeover. It may be discounted or even at fairvalue due to cheap debt. Aspen may be a potential buyer.but i think this could be a bidwes acquistion to complement adcock . Or could be an international player such as fuji . Japanese debt is extremely cheap and remedicas portfolio and footprint with ascendis gives an african market entry. This is absolute speculation.

I got a few shares cheap hoping the volume is due to inside info on a tuesday sens... either way.....lobe the share, dont live the debt, and certainly not a steinhof with litigation hanging over it....

Have a great weekend....and pls....if anyone has any negative info....pls post

Sent from my SM-G950F using Sharenet Sharechat mobile app

[Pilotpilot]

This share is strange. We are in the worse crisis wrt COVID and this share is moving lower as opposed to trading sideways or upwards

Either people that have allot money are playing here and driving this share down to suit there own gains or we are in store for rocky results

 

I see it as a buying opportunity:)

 

There is some share manipulation. Share price drops with 3000 volume sale . Its a pity our jse is so hopeless that they cant pick up price manipulation. This share is held majority by institutional investors and share price moving on 0.02% volume. So all abstract. I would say if there is a dip use every opportunity to buy. The only negative news would be remedica sold for 100million usd.....or something...
Everyone is pro this share. So buy the dip...

Sent from my SM-G950F using Sharenet Sharechat mobile app

 

I agree with you guys. This is one of those shares like SNH, EOH, Aveng, LON etc. where these shares have been thrown like bait to the ordinary investor. The valuations are crazy and yet the price keeps going lower. Investors keep them for years and eventually the company gets taken over, liquidated, sold off, or goes under management. 

 

I did post about this in 2 posts..... here  and here ,  if you want to read more.

 

There might, or might not be a takeover, but this share price is definitely not moving normally. As soon as I realized it, I removed it from my share list. Steinhoff has the same issue if you read the second post.

 

There is a couple of other theories that could be happening, but that is a long story.....

 

Safe trading guys 

[Investment novice]

Hi. There should be a sens out , this is what we waiting on. It is cheaper for a big player to buy the shareholders out and refinance the debt and hold the assets then to go an buy remedica for a premium. Take the whole lot.

Not sure if this is a reality as even a preliminary meeting has to have a sens issued. Though there could he potential dancers.

Hypothetically. I would be happy to sell all ky shares for r10 a share. Thats 250 million euros....for the 500 million shares...cheap when you put it that way
.

250 million and debt at 200 million , big entity with a powerful balance sheet will enjoy the assets and footprint....and grow this company to the next level....


Sent from my SM-G950F using Sharenet Sharechat mobile app

[Leadingedge]

I am excited to finally be part of this forum, I have been watching from the sidelines for many months.

 

I am equally excited about the potential of this share, but today has caught me by surprise. I know I am an utter greenhorn when it comes to the technical aspects of share trading and assessing a company, but this does not make sense at all.

 

There is a rumour out there of a possible take-over happening behind the scenes, but it is pure speculation.

 

Maybe useless information but this is the first time since March, on the daily chart, that we are into oversold territory. Over 1.7million shares traded today already and counting.

 

Unfortunately with any company/share there will always be that aspect of what we don't know.

[Investment novice]

Well...now more shares being traded.....who knows..
But this is true...company has good revenue end dec 2019 pre covid which was brilliant for sustainability ...and then opportunistically had covid revenue and now in the new world will have revenue for the new world....
Dont look at value of share you have....try to either hold or buy the dip.....only lose if you sell.....

Sent from my SM-G950F using Sharenet Sharechat mobile app

[DeltaHedge]

There is some share manipulation. Share price drops with 3000 volume sale . Its a pity our jse is so hopeless that they cant pick up price manipulation. This share is held majority by institutional investors and share price moving on 0.02% volume. So all abstract. I would say if there is a dip use every opportunity to buy. The only negative news would be remedica sold for 100million usd.....or something...
Everyone is pro this share. So buy the dip...
Sent from my SM-G950F using Sharenet Sharechat mobile app

Thanks for the perspective, good to know it’s such little volume creating an untrue reflection on price.

[Investment novice]

Could also be general market sell off..time in the market......not timing.....end september you will be smiling

Sent from my SM-G950F using Sharenet Sharechat mobile app

[DeltaHedge]

This share is strange. We are in the worse crisis wrt COVID and this share is moving lower as opposed to trading sideways or upwards
Either people that have allot money are playing here and driving this share down to suit there own gains or we are in store for rocky results
 
I see it as a buying opportunity:)

Right now I am getting my balls handed to me on a plate, maybe insiders have info already ? Let’s hope this thing catches a bid soon.

[Investment novice]

There is some share manipulation. Share price drops with 3000 volume sale . Its a pity our jse is so hopeless that they cant pick up price manipulation. This share is held majority by institutional investors and share price moving on 0.02% volume. So all abstract. I would say if there is a dip use every opportunity to buy. The only negative news would be remedica sold for 100million usd.....or something...
Everyone is pro this share. So buy the dip...

Sent from my SM-G950F using Sharenet Sharechat mobile app

[vishalsur]

This share is strange. We are in the worse crisis wrt COVID and this share is moving lower as opposed to trading sideways or upwards

Either people that have allot money are playing here and driving this share down to suit there own gains or we are in store for rocky results

 

I see it as a buying opportunity:)

[DeltaHedge]

It looks a bit sick today, is there any news out ?

[Investment novice]

Thanks Andi. Scitec factored in and impaired tragically.
Revenue june 2020 include remedica which was not accounted for. I agree difficult to predict the ebitda. I want to hazard r1.3 - r1.5b adjusting for rand dollar depreciation

With the ebitda at this range be interesting the amounts swept to reduce debt, the change in ginancial ratios and the plan to offset some equity in remedica not the 100% stake. Also debt refinancing will be possible with clean financials and a 2020 afs as a going concern


Sent from my SM-G950F using Sharenet Sharechat mobile app

[andi222]

Hi IN,

 

It's really tough to say where EBITDA will fall. My best guess would be somewhere around 1.3 billion. However I can be considerably wrong. We will have to wait and see.

 

The latest negative I've seen is the sale of Scitec. Can't believe that they have bought this for around 200 Million € and they have sold it now for 5 Million plus keeping the negative liabilities. 

 

However this is already priced into the share. Let's wait for that first trading update and hopefully it will be very positive.

[Investment novice]

I learnt today about the compounding pharmacy .
Not sure market knowldge on a number of the ascendis assets. Needless to say that SA dr have applied a functional medicine approach which includes national adoption of vitamin protocols as well as mainstream medicine to treat covid. As well as to boost immunity. Many of the hospital based treatments include iv vitamin c. Short in stock and expensive. Any guesses which company provides this....
Potentially Ascendis could do alot better with their marketing...sad that we have to learn this haphazardly.

Please can anyone advise any negatives except for debt levels

And Andi...whats your call on ebitda...i suspect 30% additional on dec 2019
As a middle road..
Sent from my SM-G950F using Sharenet Sharechat mobile app

[Investment novice]

Andi do you have the latest shareholder lists for ascendis at the end of july?


Sent from my SM-G950F using Sharenet Sharechat mobile app

[Investment novice]

Cant time this market...think its a risk benefit...do you wait out to drop another 10c and lose out upside 50c. I just buy when i have cash at the best price...
No guarantee of any price low or high...buy within the safety margin...

Sent from my SM-G950F using Sharenet Sharechat mobile app

[SB45]

I saw 77c earlier today, missed it. My buying range 80 - 90c . Do you see it going lower ? I like to take a nibble at lower prices as they won't last for long.

[Investment novice]

Time to pickup ...or wait for lower levels...or hold cash for d1 of the blitz

Sent from my SM-G950F using Sharenet Sharechat mobile app

[Investment novice]

Hi. I am a pumper here. On others i posted cauation when i think a share is worrisome .

I really hope we all can make money out of this. Andi and i have been watching and buying the share for 8 months since it dipped under r1.

It had good prospects...but covid made it great prospects.


Do your own leg work...and let me know....i drove to the company and spent time watching the trucks in and out. Got to sorak to staff. Technitians etc....

I have all of my high risk funds in this single share as of friday. Expecting a update the next two weeks and full year in september.

After the market frenzy i will sell 50% and redistribute.

Dont trust me....but if you do make money donate 5 % to charity...

Many will be quiet and wont talkup...but watch the commentary once the first voluntary update comes out.

I would suggest hold cash and when the update comes out you will have a chance to get in day one....and there will be a high ride for a few days...

Sent from my SM-G950F using Sharenet Sharechat mobile app

[Blackobar]

I appreciate your response I.N. I can tell you're invested and excited about the prospects of the company, and I'm not mad at you for that. Looking at Remedica, It'd be great if they can keep Remedica. From the little digging i've done, it is a great business. But I understand the debt is huge.